APLS icon

Apellis Pharmaceuticals
APLS

Overview Fund Activity

262 hedge funds and large institutions have $4.43B invested in Apellis Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 126 increasing their positions, 66 reducing their positions, and 66 closing their positions.

Holders
262
Holders Change
-38
Holders Change %
-12.67%
% of All Funds
3.81%
Holding in Top 10
5
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-37.5%
% of All Funds
0.07%
New
32
Increased
126
Reduced
66
Closed
66
Calls
$230M
Puts
$50M
Net Calls
+$180M
Net Calls Change
+$163M

Top Buyers

1
DTC
1
Deep Track Capital
Connecticut
$95.9M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$629M
3
State Street
3
State Street
Massachusetts
$159M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$127M
5
JPMorgan Chase & Co
5
JPMorgan Chase & Co
New York
$122M

Top Sellers

1
FLSM
1
Frazier Life Sciences Management
California
$0
2
Assenagon Asset Management
2
Assenagon Asset Management
Luxembourg
$28.2M
3
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$49M
4
Citadel Advisors
4
Citadel Advisors
Florida
$5.9M
5
ITP
5
Iron Triangle Partners
Connecticut
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Wellington Management Group
1
Wellington Management Group
Massachusetts
$629M 16,388,697 +1,330,626 +9%
EC
2
EcoR1 Capital
California
$445M 11,607,425 +250,000 +2%
ACA
3
Avoro Capital Advisors
New York
$426M 11,111,111 – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$376M 9,809,552 +303,686 +3%
BlackRock
5
BlackRock
New York
$222M 5,795,272 +300,681 +5%
State Street
6
State Street
Massachusetts
$159M 4,146,694 +1,237,166 +43%
T. Rowe Price Investment Management
7
T. Rowe Price Investment Management
Maryland
$155M 4,048,412 -557,309 -12%
Jennison Associates
8
Jennison Associates
New York
$138M 3,591,416 +350,903 +11%
Fidelity Investments
9
Fidelity Investments
Massachusetts
$127M 3,299,790 +1,121,048 +51%
JPMorgan Chase & Co
10
JPMorgan Chase & Co
New York
$122M 3,177,470 +963,161 +43%
OCA
11
Octagon Capital Advisors
New York
$111M 2,880,880 +73,900 +3%
DTC
12
Deep Track Capital
Connecticut
$95.9M 2,500,000 +1,500,000 +150%
Morgan Stanley
13
Morgan Stanley
New York
$81.3M 2,118,897 +481,279 +29%
Deutsche Bank
14
Deutsche Bank
Germany
$70.7M 1,842,042 +230,269 +14%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$68.6M 1,787,917 +98,027 +6%
BC
16
Boxer Capital
California
$66.2M 1,726,000 – –
AG
17
Artal Group
Luxembourg
$56.3M 1,467,080 +151,798 +12%
Fiera Capital (Canada)
18
Fiera Capital (Canada)
Quebec, Canada
$53.7M 1,401,190 +452,753 +48%
O
19
OrbiMed
New York
$50M 1,302,800 +5,000 +0.4%
T. Rowe Price Associates
20
T. Rowe Price Associates
Maryland
$49M 1,276,426 -1,182,820 -48%
Invesco
21
Invesco
Georgia
$42.3M 1,102,833 +340,718 +45%
Norges Bank
22
Norges Bank
Norway
$41.4M 1,079,605 +71,685 +7%
PCH
23
Polar Capital Holdings
United Kingdom
$41.4M 1,079,440 +25,000 +2%
Bank of America
24
Bank of America
North Carolina
$38.2M 995,069 +271,625 +38%
Charles Schwab
25
Charles Schwab
California
$36.3M 947,034 +22,472 +2%
1
2 3 4 5